merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>No therapies to offer for people without cognitive impairment who have Alzheimer's pathology, and risk of anxiety and other psychological reactions to such test results</answer>

<question_number>2</question_number>
<answer>The blood test was wrong only about 10% of the time, while primary care doctors were wrong 41% of the time when they thought patients did not have Alzheimer's</answer>

<question_number>3</question_number>
<answer>Many people with subjective cognitive decline do not turn out to have Alzheimer's</answer>

<question_number>4</question_number>
<answer>Blood test analysis needs to be easily integrated into hospital laboratory systems rather than requiring outside labs</answer>

<question_number>5</question_number>
<answer>ptau-217</answer>

<question_number>6</question_number>
<answer>Only for people with memory loss and other symptoms of cognitive decline, not for people who are cognitively healthy</answer>

<question_number>7</question_number>
<answer>Kidney disease</answer>

<question_number>8</question_number>
<answer>Risk of anxiety and other psychological reactions to test results</answer>

<question_number>9</question_number>
<answer>41 percent</answer>

<question_number>10</question_number>
<answer>N/A</answer>
<other>The article mentions that Dr. Boxer and Dr. Karlawish hope blood tests in primary care would increase access to screening for people from racial and ethnic minorities and low-income and rural communities, but doesn't specifically attribute this statement to Dr. Boxer alone.</other>